RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients (2017)
- Authors:
- Dezana, Marcia R.
- Ribeiro, Ingrid Helena
- Oliveira, Valéria B.
- Vieira, Juliana B.
- Gomes, Francisco C.
- Franco, Lucas Augusto Moysés
- Varuzza, Leonardo
- Ribeiro, Roberto
- Chinoca, Karen Ziza
- Levi, José Eduardo
- Krieger, Jose Eduardo
- Pereira, Alexandre Costa
- Gualandro, Sandra Fátima Menosi
- Rocha, Vanderson Geraldo
- Mendrone Júnior, Alfredo
- Sabino, Ester Cerdeira
- Dinardo, Carla Luana
- USP affiliated authors: KRIEGER, JOSE EDUARDO - FM ; GUALANDRO, SANDRA FATIMA MENOSI - FM ; ROCHA, VANDERSON GERALDO - FM ; SABINO, ESTER CERDEIRA - FM
- Unidade: FM
- DOI: 10.1016/j.bcmd.2017.03.014
- Subjects: GENÓTIPOS; TÉCNICAS CITOLÓGICAS; REAÇÃO EM CADEIA POR POLIMERASE; TRANSFUSÃO DE SANGUE; SEQUENCIAMENTO GENÉTICO
- Language: Inglês
- Imprenta:
- Publisher place: California
- Date published: 2017
- Source:
- Título: Blood Cells, Molecules, and Diseases
- ISSN: 1079-9796
- Volume/Número/Paginação/Ano: v. 65, n. 1, p. 8-15, 2017
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
DEZANA, Marcia R. et al. RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients. Blood Cells, Molecules, and Diseases, v. 65, n. 1, p. 8-15, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.bcmd.2017.03.014. Acesso em: 01 jan. 2026. -
APA
Dezana, M. R., Ribeiro, I. H., Oliveira, V. B., Vieira, J. B., Gomes, F. C., Franco, L. A. M., et al. (2017). RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients. Blood Cells, Molecules, and Diseases, 65( 1), 8-15. doi:10.1016/j.bcmd.2017.03.014 -
NLM
Dezana MR, Ribeiro IH, Oliveira VB, Vieira JB, Gomes FC, Franco LAM, Varuzza L, Ribeiro R, Chinoca KZ, Levi JE, Krieger JE, Pereira AC, Gualandro SFM, Rocha VG, Mendrone Júnior A, Sabino EC, Dinardo CL. RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients [Internet]. Blood Cells, Molecules, and Diseases. 2017 ; 65( 1): 8-15.[citado 2026 jan. 01 ] Available from: https://doi.org/10.1016/j.bcmd.2017.03.014 -
Vancouver
Dezana MR, Ribeiro IH, Oliveira VB, Vieira JB, Gomes FC, Franco LAM, Varuzza L, Ribeiro R, Chinoca KZ, Levi JE, Krieger JE, Pereira AC, Gualandro SFM, Rocha VG, Mendrone Júnior A, Sabino EC, Dinardo CL. RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients [Internet]. Blood Cells, Molecules, and Diseases. 2017 ; 65( 1): 8-15.[citado 2026 jan. 01 ] Available from: https://doi.org/10.1016/j.bcmd.2017.03.014 - -318C/T polymorphism of the CTLA-4 gene is an independent risk factor for RBC alloimmunization among sickle cell disease patients
- Effectiveness of strategies to screen for blood donors with RH variants in a mixed population
- Prevalence and laboratorial determinants of the clinical relevance of antibodies of undetermined specificity
- SMIM1 intron 2 gene variations leading to variability in Vel antigen expression among Brazilian blood donors
- High frequency of variant RHD genotypes among donors and patients of mixed origin with serologic weak-D phenotype
- Massive autoimmune hemolysis documented by monocyte monolayer assay in a multiply transfused patient using reticulocytes isolated by simple centrifugation in microhematocrit tubes
- Impact of HLA-G+3142C>G on the development of antibodies to blood group systems other than the Rh and Kell among sensitized patients with sickle cell disease
- Risk factors for deferral due to low hematocrit and iron depletion among prospective blood donors in a Brazilian center
- Short form health survey (SF-36) differs between genotypic groups of patients with suspected hereditary hemochromatosis
- Quality of life scores differs between genotypic groups of patients with suspected hereditary hemochromatosis
Informações sobre o DOI: 10.1016/j.bcmd.2017.03.014 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
